google_counter
Removal of prostate tumor metastases with a gamma probe (694716) | University Hospital Frankfurt am Main - BookingHealth
{"translation_price":"50","translation_doc_price":"40","child_coefficient":"1.1","transfer_price":"2.00","transfer_price_vip":"5.00","constant_transfer_price_vip":350,"constant_transfer_price":150,"constant_transfer_distanse":60,"type":"treatment","program_full_story":"<ul>\n\t<li>Initial presentation in the hospital<\/li>\n\t<li>Clinical history taking<\/li>\n\t<li>Evaluating the available medical reports<\/li>\n\t<li>General clinical examination<\/li>\n\t<li>Urological examination<\/li>\n\t<li>Laboratory tests:\n\t<ul>\n\t\t<li>Complete blood count<\/li>\n\t\t<li>Biochemical analysis of blood<\/li>\n\t\t<li>Inflammation indicators (CRP, ESR)<\/li>\n\t\t<li>Indicators of blood coagulation<\/li>\n\t\t<li>Tumor markers, PSA<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>Ultrasound scan of the urogenital system<\/li>\n\t<li>CT scan\/MRI of the abdomen and pelvis<\/li>\n\t<li>Preoperative care<\/li>\n\t<li>Removal of prostate tumor metastases with a gamma probe<\/li>\n\t<li>Consultations of related specialists<\/li>\n\t<li>Symptomatic treatment<\/li>\n\t<li>Cost of essential medicines<\/li>\n\t<li>Nursing services<\/li>\n\t<li>Control examinations<\/li>\n\t<li>Stay in the hospital with full board<\/li>\n\t<li>Accommodation in 2-bedded ward<\/li>\n\t<li>Recommendations regarding further treatment<\/li>\n<\/ul>\n<div class=\"program_indications_for_surgery\"><h4>Indications<\/h4><ul>\n\t<li>Confirmed prostate cancer with suspected metastasizing<\/li>\n<\/ul>\n<\/div><div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>, the physician will conduct a clinical examination and go through the results of the available examinations. After that, you will undergo the necessary additional examination, such as the assessment of liver and kidney function, ultrasound scan of the abdominal and pelvic organs. Based on the results, the physician will determine the number and localization of metastases, and plan the upcoming intervention.<\/p>\n\n<p style=\"text-align:justify\"><strong>On the eve of the intervention<\/strong>, you will receive an injection of radioactively labeled PSMA. PSMA is the substance that binds to the smallest prostate cancer metastases in the lymph nodes and other tissues. The radioactive label will allow the surgeon to find all the metastases during the operation.<\/p>\n\n<p style=\"text-align:justify\"><strong>Removal of prostate tumor metastases with a gamma probe<\/strong> starts with general anesthesia. After anesthesia, the surgeon makes small incisions through which he inserts endoscopic instruments, a gamma probe and a video camera into the pelvic cavity and abdominal cavity. The gamma probe detects the lymph nodes affected by metastases by a radioactive label, and the surgeon removes them endoscopically. The video camera continuously transmits a three-dimensional image of the operating field in 12-fold magnification to the monitor.<\/p>\n\n<p style=\"text-align:justify\">As the surgeon sees the operating field in multiple magnification, he preserves the nerve endings and large blood vessels. This significantly reduces the surgical risks. The gamma probe, in turn, allows detecting and removing all metastases, which minimizes the risk of prostate cancer recurrence.<\/p>\n\n<p style=\"text-align:justify\"><strong>After the completion of the operation<\/strong>, you will be transferred back to the ward, under the supervision of the attending physician and nursing staff. Due to the minimal invasiveness of the operation and the short duration of general anesthesia, you will not need to stay in the intensive care unit for a long time.<\/p>\n\n<p style=\"text-align:justify\">Finally, the attending physician will evaluate the results of control examinations, schedule the date of discharge from the hospital and give you detailed recommendations for further follow-up and treatment.<\/p>\n<\/div><div class=\"program_required_documents mt-4\"><h4>Required documents<\/h4><ul>\n\t<li style=\"text-align: justify;\">Medical records<\/li>\n\t<li style=\"text-align: justify;\">PSA blood test<\/li>\n\t<li style=\"text-align: justify;\">MRI\/CT scan (not older than 3 months)<\/li>\n\t<li style=\"text-align: justify;\">Bone scintigraphy (if available)<\/li>\n\t<li style=\"text-align: justify;\">Biopsy results (if available)<\/li>\n<\/ul>\n<\/div>","program_full_story_crm":"<ul>\n\t<li>Initial presentation in the hospital<\/li>\n\t<li>Clinical history taking<\/li>\n\t<li>Evaluating the available medical reports<\/li>\n\t<li>General clinical examination<\/li>\n\t<li>Urological examination<\/li>\n\t<li>Laboratory tests:\n\t<ul>\n\t\t<li>Complete blood count<\/li>\n\t\t<li>Biochemical analysis of blood<\/li>\n\t\t<li>Inflammation indicators (CRP, ESR)<\/li>\n\t\t<li>Indicators of blood coagulation<\/li>\n\t\t<li>Tumor markers, PSA<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>Ultrasound scan of the urogenital system<\/li>\n\t<li>CT scan\/MRI of the abdomen and pelvis<\/li>\n\t<li>Preoperative care<\/li>\n\t<li>Removal of prostate tumor metastases with a gamma probe<\/li>\n\t<li>Consultations of related specialists<\/li>\n\t<li>Symptomatic treatment<\/li>\n\t<li>Cost of essential medicines<\/li>\n\t<li>Nursing services<\/li>\n\t<li>Control examinations<\/li>\n\t<li>Stay in the hospital with full board<\/li>\n\t<li>Accommodation in 2-bedded ward<\/li>\n\t<li>Recommendations regarding further treatment<\/li>\n<\/ul>\n<div class=\"program_indications_for_surgery\"><h4>Indications<\/h4><ul>\n\t<li>Confirmed prostate cancer with suspected metastasizing<\/li>\n<\/ul>\n<\/div><div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>, the physician will conduct a clinical examination and go through the results of the available examinations. After that, you will undergo the necessary additional examination, such as the assessment of liver and kidney function, ultrasound scan of the abdominal and pelvic organs. Based on the results, the physician will determine the number and localization of metastases, and plan the upcoming intervention.<\/p>\n\n<p style=\"text-align:justify\"><strong>On the eve of the intervention<\/strong>, you will receive an injection of radioactively labeled PSMA. PSMA is the substance that binds to the smallest prostate cancer metastases in the lymph nodes and other tissues. The radioactive label will allow the surgeon to find all the metastases during the operation.<\/p>\n\n<p style=\"text-align:justify\"><strong>Removal of prostate tumor metastases with a gamma probe<\/strong> starts with general anesthesia. After anesthesia, the surgeon makes small incisions through which he inserts endoscopic instruments, a gamma probe and a video camera into the pelvic cavity and abdominal cavity. The gamma probe detects the lymph nodes affected by metastases by a radioactive label, and the surgeon removes them endoscopically. The video camera continuously transmits a three-dimensional image of the operating field in 12-fold magnification to the monitor.<\/p>\n\n<p style=\"text-align:justify\">As the surgeon sees the operating field in multiple magnification, he preserves the nerve endings and large blood vessels. This significantly reduces the surgical risks. The gamma probe, in turn, allows detecting and removing all metastases, which minimizes the risk of prostate cancer recurrence.<\/p>\n\n<p style=\"text-align:justify\"><strong>After the completion of the operation<\/strong>, you will be transferred back to the ward, under the supervision of the attending physician and nursing staff. Due to the minimal invasiveness of the operation and the short duration of general anesthesia, you will not need to stay in the intensive care unit for a long time.<\/p>\n\n<p style=\"text-align:justify\">Finally, the attending physician will evaluate the results of control examinations, schedule the date of discharge from the hospital and give you detailed recommendations for further follow-up and treatment.<\/p>\n<\/div>","is_ambulant":"0","bh_fee":0,"only_for_children":"2","no_service":"0","with_prepayment":"1","show_calculator":"1","paket_type":"1","btn_type":"0","clinic_icon":"60018b76e5d59.jpg","city":"Frankfurt am Main","clinic_site":"http:\/\/www.kgu.de","department_recommend":"1","country":"Germany","country_id":"1","clinic_name":"University Hospital Frankfurt am Main","cinic_name":"University Hospital Frankfurt am Main","department_id":"1642","duration":"5","direction":"Urology","min_duration":0,"clinic_id":"256","paketPrice":850,"paket":"<ul>\n <li>Interpreter up to 3 hours<\/li>\n <li>Translation of 2 pages<\/li>\n<\/ul>","title":"Removal of prostate tumor metastases with a gamma probe","price":{"val":"0.00","type":"val"},"price_surcharge":0,"price_surcharge_clear":0,"extra_service_clinic":[{"id":"need_to_use_head_doctor","title":"Treatment by leading experts","type":"val","val":0,"req":0},{"id":"1_person_room","title":" Single room (whole period)","parent":"duration","type":"count_val","val":"130.00"},{"id":"2_person_room","title":" double room (whole period)","parent":"duration","type":"count_val","val":"90.00"},{"id":"attendant_place","title":"Accommodation for the accompanying person ","parent":"duration","type":"count_val","val":"90.00"}],"extra_service":[],"translation_hours":"0","translation_doc_count":null,"roads":[{"id":"6","distance":"10","airport_title":"Frankfurt a.M."},{"id":"19","distance":"218","airport_title":"Stuttgart"},{"id":"4","distance":"430","airport_title":"Duesseldorf"}],"pakets":[],"lang":{"day":"Day","days":"days","ambulatory":"Outpatient","stationaryProgram":"Inpatient"}}

Removal of prostate tumor metastases with a gamma probe

University Hospital Frankfurt am Main

Frankfurt am Main, Germany
Program id # 694716
Doctor photo
Prof. Dr. med. Frank Grünwald
Department of Nuclear Medicine
Specialized in: nuclear medicine

The program includes:

  • Initial presentation in the hospital
  • Clinical history taking
  • Evaluating the available medical reports
  • General clinical examination
  • Urological examination
  • Laboratory tests:
    • Complete blood count
    • Biochemical analysis of blood
    • Inflammation indicators (CRP, ESR)
    • Indicators of blood coagulation
    • Tumor markers, PSA
  • Ultrasound scan of the urogenital system
  • CT scan/MRI of the abdomen and pelvis
  • Preoperative care
  • Removal of prostate tumor metastases with a gamma probe
  • Consultations of related specialists
  • Symptomatic treatment
  • Cost of essential medicines
  • Nursing services
  • Control examinations
  • Stay in the hospital with full board
  • Accommodation in 2-bedded ward
  • Recommendations regarding further treatment

Indications

  • Confirmed prostate cancer with suspected metastasizing

How program is carried out

During the first visit, the physician will conduct a clinical examination and go through the results of the available examinations. After that, you will undergo the necessary additional examination, such as the assessment of liver and kidney function, ultrasound scan of the abdominal and pelvic organs. Based on the results, the physician will determine the number and localization of metastases, and plan the upcoming intervention.

On the eve of the intervention, you will receive an injection of radioactively labeled PSMA. PSMA is the substance that binds to the smallest prostate cancer metastases in the lymph nodes and other tissues. The radioactive label will allow the surgeon to find all the metastases during the operation.

Removal of prostate tumor metastases with a gamma probe starts with general anesthesia. After anesthesia, the surgeon makes small incisions through which he inserts endoscopic instruments, a gamma probe and a video camera into the pelvic cavity and abdominal cavity. The gamma probe detects the lymph nodes affected by metastases by a radioactive label, and the surgeon removes them endoscopically. The video camera continuously transmits a three-dimensional image of the operating field in 12-fold magnification to the monitor.

As the surgeon sees the operating field in multiple magnification, he preserves the nerve endings and large blood vessels. This significantly reduces the surgical risks. The gamma probe, in turn, allows detecting and removing all metastases, which minimizes the risk of prostate cancer recurrence.

After the completion of the operation, you will be transferred back to the ward, under the supervision of the attending physician and nursing staff. Due to the minimal invasiveness of the operation and the short duration of general anesthesia, you will not need to stay in the intensive care unit for a long time.

Finally, the attending physician will evaluate the results of control examinations, schedule the date of discharge from the hospital and give you detailed recommendations for further follow-up and treatment.

Required documents

  • Medical records
  • PSA blood test
  • MRI/CT scan (not older than 3 months)
  • Bone scintigraphy (if available)
  • Biopsy results (if available)

Service

Price:
Type of program :
Price for 1 day:
Expected duration of the program:
The minimum duration of the program:
Select

You may also book:

Guarantee Price:

About the department

The Department of Nuclear Medicine at the University Hospital Frankfurt am Main offers the full range of modern diagnostics and therapy using various radioisotopes.

The department is headed by Prof. Dr. med. Frank Grünwald. In 1990, the doctor had his board certification in nuclear medicine, after which he worked for about 10 years at the University Hospital Bonn. At the moment, Prof. Grünwald, who has over 30 years of experience in treating patients with radionuclide methods, is recognized as one of the best specialists in Germany. He always makes every effort to ensure that his patients receive first-class medical care. The doctor has special experience in radioiodine therapy, positron emission tomography, and the use of radionuclide methods for cancer treatment. He is a member of many professional organizations and a winner of awards for his scientific work. He authored about 90 publications in the scientific literature, as well as some full books and individual chapters of books on nuclear medicine.

The department is equipped with the advanced systems for carrying out such high-precision and informative examinations as SPECT, PET, etc. The department carries out more than 8,000 outpatient examinations annually. The key focus in the field of diagnostics is on the detection of neurological, cardiac and oncological diseases. The department's therapeutic options include the treatment of benign and malignant diseases of the thyroid gland, pain therapy in bone metastases, treatment of malignant tumors in children (for example, neuroblastomas). The spectrum is also complemented by such innovative techniques as radiosynoviorthesis, selective internal radiation therapy and radioimmunotherapy.

Of particular interest to the department's specialists is the diagnostics and treatment of thyroid diseases. To make an accurate diagnosis, they conduct reliable and proven examinations, such as ultrasound and scintigraphy. The doctors mostly have to deal with such pathologies as goiter, thyroid hyperfunction and hypofunction, Graves' disease, thyroid inflammations, thyroid cancer. Once an accurate diagnosis is made, the doctor will develop an individualized treatment regimen aimed at the successful treatment outcome. One of the most common treatment methods is radioiodine therapy.

The service range of the department includes:

Diagnostics
  • Thyroid scintigraphy
  • (Whole-body) scintigraphy using iodine after the surgical removal of the thyroid gland
  • Brain scintigraphy
  • Kidney scintigraphy
  • Skeletal scintigraphy
  • Heart scintigraphy
  • Parathyroid scintigraphy
  • Lung scintigraphy
  • Tumor scintigraphy using mIBG
  • Sentinel lymph node scintigraphy
  • PET-CT
  • SPECT
Therapy
  • Radioiodine therapy
  • Radium therapy (Ra-223) in pain syndrome caused by bone metastases
  • 177Lu-PSMA-617 radioligand therapy
  • Lu-177 radio peptide therapy
  • Selective internal radiation therapy
  • Radioimmunotherapy
  • Radiosynoviorthesis
  • 131I-MIBG therapy
Other diagnostic examinations and treatment methods 

Curriculum vitae

  • 1978 - 1984 Study of Human Medicine at the University of Bonn.
  • 1984 Medical state examination.
  • 1984 Admission to medical practice.
  • 1984 - 1986 Research Fellow at the Institute of Physiology I of the University of Bonn. 
  • 1986 Doctoral Degree.
  • 1986 Research Fellow in the Department of Nuclear Medicine at the University of Bonn 
  • 1990 Board certification in Nuclear Medicine.
  • 1992 Habilitation in Nuclear Medicine and appointment as PD.
  • 1992 Senior Physician in the Department of Nuclear Medicine.
  • 1994 Leading Senior Physician in the Department of Nuclear Medicine. 
  • 1997 Appointed as an Extraordinary Professor.
  • 1999 Taking up the duties as the Head of the Department of Nuclear Medicine at the University Hospital Frankfurt am Main.

 Photo of the doctor: (c) Universitätsklinikum Frankfurt 

Sources:

Wikipedia

PubMed, National Library of Medicine


About hospital

According to the reputable Focus magazine, the University Hospital Frankfurt am Main ranks among the top German medical facilities! 

The hospital was founded in 1914 and today is a well-known German medical facility, which combines rich traditions and scientific innovations. A medical team of more than 6,500 employees cares about the health of patients around the clock, ensuring them with the highest standards of medical care and best possible safety.

The hospital has 32 specialized departments and more than 20 research institutes, which have all the necessary resources for the provision of the most effective care for any patient. The hospital has 1,488 beds for inpatient medical care. The medical facility diagnoses and treats more than 51,000 inpatients and about 44,800 outpatients every year. Due to the demonstration of outstanding treatment results, the number of patients seeking medical care here increases significantly annually.

The hospital presents all areas of modern medicine, whereas its special competence lies in neuroscience, oncology, cardiovascular medicine, cardiac surgery and other fields. Many treatment methods available here are unique not only in Europe, but also internationally.

Photo: (c) depositphotos

Accommodation in hospital

Patients rooms

The patients of the University Hospital Frankfurt am Main live in comfortable rooms made in modern design and meeting the highest standards of European medicine. Each room is equipped with an ensuite bathroom with a toilet and a shower. The standard room includes a comfortable, automatically adjustable bed, a bedside table, a wardrobe, a table and chairs for receiving visitors and a TV. If desired, patients can use Wi-Fi. The patients can also stay in the enhanced-comfort rooms.

Meals and Menus

The patient and his accompanying person have a daily choice of three menus. If for any reason you do not eat all the food, you will be offered an individual menu. Please inform the medical staff about your dietary preferences prior to the treatment.

Further details

Standard rooms include:

Toilet
Shower
Wi-Fi
TV

Religion

Religious services are available upon request.

Accompanying person

During the inpatient program, an accompanying person may stay with you in a patient room or in a hotel of your choice.

Hotel

During the outpatient program, you may stay in a hotel of your choice. Managers will help you choose the most suitable options.